Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas is advancing two late-stage, potential franchise molecules, obexelimab and orelabrutinib. Obexelimab, Zenas’ lead product candidate, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s unique mechanism of action and self-administered, subcutaneous injection regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease. Orelabrutinib is a potentially best-in-class, highly selective CNS-penetrant, oral, small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with the potential to address compartmentalized inflammation and disease progression in Multiple Sclerosis (MS). Zenas’ earlier stage programs include a preclinical, potentially best-in-class, oral, IL-17AA/AF inhibitor, and a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor. We are seeking top talent who share our commitment to patients and have a track record of success in acquiring, developing and commercializing products across the globe. Our colleagues have an opportunity to engage in a fast-paced learning environment and experience individual and organizational success as we work towards becoming a global immunology and autoimmune disease leader, while living our values of Transparency, Relationships, Urgency, Excellence and Innovation – TRUE Innovation! Position Summary: The Senior Director, Access Strategy & Patient Services is responsible for designing and leading the patient access strategy to ensure seamless patient services operations to facilitate timely and appropriate access to Zenas BioPharma therapies. Reporting to the Vice President, U.S. Market Access, this role will lead the development of the patient journey strategy, HUB services model, affordability programs, and provider onboarding processes to ensure patients and providers can successfully navigate access to therapy. This individual will play a critical role in establishing the patient access infrastructure ahead of anticipated product launches, lead the establishment and operationalization of the patient support HUB, design the prior authorization support pathways, implement affordability assistance programs, and ensure effective coordination with specialty pharmacy partners to support efficient patient onboarding and therapy initiation. The Senior Director will collaborate closely with cross-functional partners including Market Access Operations, Payer Strategy, Pricing & Contracting, Medical Affairs, Compliance, Legal, and Sales to ensure a coordinated and compliant approach to patient support services. This role offers a unique opportunity to design and implement the patient access ecosystem in preparation for upcoming product launches.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
11-50 employees